# Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

> **NCT07093606** · NA · RECRUITING · sponsor: **Sohag University** · enrollment: 100 (estimated)

## Conditions studied

- ITP - Immune Thrombocytopenia

## Interventions

- **DRUG:** Eltrombopag

## Key facts

- **NCT ID:** NCT07093606
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-14
- **Primary completion:** 2026-01-20
- **Final completion:** 2026-01-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07093606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07093606, "Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07093606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*